NCT06453044 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06453044
Title	Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular Lymphoma
Recruitment	Recruiting
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	City of Hope Medical Center
Indications	follicular lymphoma
Therapies	Mosunetuzumab-axgb + Polatuzumab vedotin-piiq
Age Groups:	adult \| senior
Covered Countries	USA

Showing 1 to 2 of 2 entries

Filter rows:

Facility	Status	City	State	Zip	Country	Details
City of Hope Medical Center	RECRUITING	Duarte	California	91010	United States	Details
City of Hope Orange County Lennar Foundation Cancer Center	NOT_YET_RECRUITING	Irvine	California	92618	United States	Details

Showing 1 to 2 of 2 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT06453044Clinical Trial Detail